SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-22
👔
Parabilis Medicines, Inc.
@PBLS_InsiderForm 4 Filing: RA Capital Nexus Fund III, L.P. Buys $6.9M of $PBLS
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Parabilis Medicines, Inc.
Ticker: $PBLS
Transaction Value
$6.9M
Price/Share: $28.29
transaction date
2026-07-20
Shares: 244,593
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, RA Capital Nexus Fund III, L.P., holds the title of Director at Parabilis Medicines, Inc..
On 2026-07-20, the insider transacted 244,593 shares.The shares were transacted at a weighted average price of $28.29 per share, resulting in a total market-relevant value of $6.9M.
Executive Summary Summary
RA Capital Nexus Fund III, L.P. (Director) bought $6.9M of $PBLS
Post-Transaction Position: 26,383,526 shares
SEC Accession No: 0001231919-26-000779 (CIK: 1883840)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.